Preclinical evaluation of ISH0339, a tetravalent broadly neutralizing bispecific antibody against SARS-CoV-2 with long-term protectionResearch Article Published on 2023-04-062024-09-05 Journal: Antibody Therapeutics [Category] update2024, [키워드] bispecific COVID-19 ISH0339 long-protection Neutralizing omicron SARS-CoV-2 tetravalent [DOI] 10.1093/abt/tbad003 PMC 바로가기 [Article Type] Research Article